Avantor® Announces Filing of Registration Statement for Initial Public Offering
Radnor, Pa, February 8,2019 – Avantor, Inc., a leading global provider of mission critical products and services to customersin the Biopharma, Healthcare, Education & Government, and Advanced Technologies & Applied Materials industries, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering (“IPO”) and listing of Avantor’s common stock.
A registration statement relating to the proposed IPO has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.